ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc (HEMO)

1,299
-0,016
(-1,22%)
Geschlossen 13 Oktober 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,299
Gebot
1,252
Fragen
1,346
Volumen
2.056.855
1,242 Tagesbereich 1,348
1,18 52-Wochen-Bereich 6,30
Marktkapitalisierung
Handelsende
1,315
Handelsbeginn
1,348
Letzter Handelszeitpunkt
Finanzvolumen
25.659p
VWAP
1,2475
Durchschnittliches Volumen (3 Mio.)
6.311.927
Ausgegebene Aktien
1.341.815.988
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,48
Gewinn pro Aktie (EPS)
-0,01
Erlöse
-
Nettogewinn
-6,69M

Über Hemogenyx Pharmaceuticals Plc

Sektor
Finance Services
Branche
Finance Services
Website
Hauptsitz
London, Gbr
Gegründet
-
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the Londoner Börse with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1,32p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1,18p to 6,30p.

Hemogenyx Pharmaceuticals currently has 1.341.815.988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17,64 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.48.

HEMO Neueste Nachrichten

Hemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLC

Hemogenyx Pharmaceuticals PLC 02 October 2024   2 October 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Strategic Investment from Prevail Partners, LLC...

Hemogenyx Pharmaceuticals loss narrows amid reduced expenses

Hemogenyx Pharmaceuticals PLC on Friday said its pretax loss narrowed in the first half of 2024, following a reductio ...

EARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrows

The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...

Hemogenyx Pharmaceuticals PLC Half-year Report

Hemogenyx Pharmaceuticals PLC 27 September 2024         27 September 2024     Hemogenyx Pharmaceuticals plc   ("Hemogenyx Pharmaceuticals" or the "Company")     Half-year Report   Interim...

TRADING UPDATES: Light Science Technologies wins two new contracts

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Al ...

Hemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I Trials at MD Anderson

Hemogenyx Pharmaceuticals PLC 09 September 2024   9 September 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   FLT3 Assay Ready for Phase I Trials at MD...

Hemogenyx Pharmaceuticals PLC CDX Development Update

Hemogenyx Pharmaceuticals PLC 02 September 2024     2 September 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company") CDX Development Update   Hemogenyx...

Hemogenyx Pharmaceuticals PLC Presentation at CBD S&T Conference

Hemogenyx Pharmaceuticals PLC 28 August 2024      28 August 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")  Presentation at CBD S&T Conference  ...

Hemogenyx Pharmaceuticals PLC Result of Annual General Meeting

Hemogenyx Pharmaceuticals PLC 27 June 2024   27 June 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Result of Annual General Meeting   Hemogenyx...

IN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatment

euticals PLC - biopharmaceutical company focused on treatments for blood diseases - Updates on its ongoing activities ...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.201-13.41.51.5081.24279366101.33291643DE
4-0.299-18.71088861081.59821.242105386091.55303833DE
120.0131.010886469671.28621.1863119271.47350344DE
26-0.281-17.78481012661.5821.1853467301.46440792DE
52-1.001-43.52173913042.36.31.1879329382.12183342DE
156-0.821-38.72641509432.126.31.07577624372.00789799DE
260-0.901-40.95454545452.215.3751.0591207103.24937699DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CMBCambria Africa Plc
0,45p
(100,00%)
30,16M
SLFRSlf Realisation Fund Limited
1,80p
(33,33%)
259,91k
PREMPremier African Minerals Limited
0,043p
(30,30%)
1,8B
CHARChariot Limited
2,395p
(29,74%)
22,86M
MILAMila Resources Plc
0,70p
(16,67%)
15,23M
CDLCloudbreak Discovery Plc
0,175p
(-22,22%)
8,26M
VRCIVerici Dx Plc
5,50p
(-15,38%)
795,03k
JADEJade Road Investments Limited
0,175p
(-12,50%)
295,5k
XTRXtract Resources Plc
0,70p
(-12,50%)
1,33M
GDRGenedrive Plc
2,475p
(-12,39%)
39,77M
NTVONativo Resources Plc
0,0027p
(8,00%)
2,18B
PREMPremier African Minerals Limited
0,043p
(30,30%)
1,8B
TRPTower Resources Plc
0,039p
(-2,50%)
726,24M
SYMESupply@me Capital Plc
0,005p
(11,11%)
547,07M
VASTVast Resources Plc
0,145p
(16,00%)
443,05M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock